Steroid Cream for Eczema

Recruiting in Palo Alto (17 mi)

Overseen byRobert Bissonnette, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 4

Waitlist Available

Sponsor: Innovaderm Research Inc.

Prior Safety Data

Trial Summary

What is the purpose of this trial?This study is a randomized, intraindividual study to evaluate the short-term efficacy of triamcinolone acetonide (Aristocort® C) in subjects with atopic dermatitis.

Eligibility Criteria

This trial is for adults over 18 with a confirmed diagnosis of active atopic dermatitis (AD), based on specific criteria. They must have stable AD without significant flares for the last 4 weeks and two areas of skin affected. Excluded are those with immune deficiencies, chronic infections, allergies to the study drug, pregnant or breastfeeding women, certain skin types, other interfering skin conditions or cancer within the past 5 years.

Inclusion Criteria

I am 18 years old or older.

I have been diagnosed with active atopic dermatitis.

I have had atopic dermatitis for over 6 months with no severe flare-ups in the last 4 weeks.

+1 more

Exclusion Criteria

You have a weakened immune system.

I have a long-term infectious disease.

I am allergic to triamcinolone acetonide or components of the study drug.

+6 more

Participant Groups

The trial tests Triamcinolone Acetonide (Aristocort® C) against a placebo ('Vehicle') in subjects with atopic dermatitis. It's designed as an intraindividual study where each subject receives both treatments on different parts of their body to compare effectiveness directly.

2Treatment groups

Active Control

Placebo Group

Group I: Triamcinolone Acetonide (Aristocort® C)Active Control1 Intervention

Group II: VehiclePlacebo Group1 Intervention